Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks
Citi Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $157
TD Cowen Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $162
Cardinal Health's Earnings Call Highlights Growth and Challenges
Cardinal Health Price Target Raised to $157 From $140 at Citi
Balanced Outlook: Cardinal Health's Strong Performance Amidst GMPD Volatility and Tariff Concerns
Research Alert: Cah: Business-wide Margin Expansion Leads To Earnings Beat, Guidance Raise
Cardinal Health (NYSE:CAH) Reports Strong Q3 Earnings Growth With Net Income Up To US$506M
Express News | Cardinal Health Shares up 2% After Co Raises Annual Profit Forecast
Kohl's Board Terminates CEO Ashley Buchanan for Cause
Express News | Cardinal Health Exec Says Co Has Low Risk From Pharma Tariffs Due to 1% Margin Distributor Model - Conf Call
Express News | Cardinal Health Exec Says Confident in Navigating US Healthcare Changes, Including Section 232 Review and Drug Pricing Executive Order - Conf Call
Express News | Cardinal Health Exec Anticipates $200 Mln to $300 Mln in Remaining Gross Tariff Costs in Fiscal 2026 - Conf Call
Cardinal Health | 10-Q: Q3 2025 Earnings Report
Express News | Cardinal Health Exec Says 95% of Profit Unimpacted by Tariffs - Conf Call
Cardinal Health (NYSE:CAH) Misses Q1 Revenue Estimates
Cardinal Health's Fiscal Q3 Adjusted Earnings, Revenue Rise; Fiscal 2025 Adjusted Earnings Guidance Boosted
CARDINAL HEALTH Earnings Results: $CAH Reports Quarterly Earnings
Cardinal Health Sees FY26 GMPD Segment Consistent With Profit in FY25
Cardinal Health | 8-K: Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook